Tags

Type your tag names separated by a space and hit enter

Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
Biochem Biophys Res Commun. 2005 Apr 08; 329(2):726-32.BB

Abstract

Peroxisome proliferator-activated receptor-gamma (PPARgamma) plays a critical role in peripheral glucose homeostasis and energy metabolism, and inhibits cardiac hypertrophy in non-diabetic animal models. The functional role of PPARgamma in the diabetic heart, however, is not fully understood. Therefore, we analyzed cardiac gene expression, metabolic control, and cardiac glucose uptake in male Zucker diabetic fatty rats (ZDF fa/fa) and lean ZDF rats (+/+) treated with the high affinity PPARgamma agonist pioglitazone or placebo from 12 to 24 weeks of age. Hyperglycemia, hyperinsulinemia, and hypertriglyceridemia as well as lower cardiac PPARgamma, glucose transporter-4 and alpha-myosin heavy chain expression levels were detected in diabetic ZDF rats compared to lean animals. Pioglitazone increased body weight and improved metabolic control, cardiac PPARgamma, glut-4, and alpha-MHC expression levels in diabetic ZDF rats. Cardiac [(18)F]fluorodeoxyglucose uptake was not detectable by micro-PET studies in untreated and pioglitazone treated ZDF fa/fa rats but was observed after administration of insulin to pioglitazone treated ZDF fa/fa rats. PPARgamma agonists favorably affect cardiac gene expression in type-2 diabetic rats via activation and up-regulation of cardiac PPARgamma expression whereas improvement of impaired cardiac glucose uptake in advanced type-2 diabetes requires co-administration of insulin.

Authors+Show Affiliations

Department of Medicine, University of Würzburg, Germany. pelzer_t@klinik.uni-wuerzburg.deNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15737646

Citation

Pelzer, Theo, et al. "Pioglitazone Reverses Down-regulation of Cardiac PPARgamma Expression in Zucker Diabetic Fatty Rats." Biochemical and Biophysical Research Communications, vol. 329, no. 2, 2005, pp. 726-32.
Pelzer T, Jazbutyte V, Arias-Loza PA, et al. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats. Biochem Biophys Res Commun. 2005;329(2):726-32.
Pelzer, T., Jazbutyte, V., Arias-Loza, P. A., Segerer, S., Lichtenwald, M., Law, M. P., Schäfers, M., Ertl, G., & Neyses, L. (2005). Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats. Biochemical and Biophysical Research Communications, 329(2), 726-32.
Pelzer T, et al. Pioglitazone Reverses Down-regulation of Cardiac PPARgamma Expression in Zucker Diabetic Fatty Rats. Biochem Biophys Res Commun. 2005 Apr 8;329(2):726-32. PubMed PMID: 15737646.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats. AU - Pelzer,Theo, AU - Jazbutyte,Virginija, AU - Arias-Loza,Paula Anahi, AU - Segerer,Stephan, AU - Lichtenwald,Margit, AU - Law,Marilyn P, AU - Schäfers,Michael, AU - Ertl,Georg, AU - Neyses,Ludwig, PY - 2005/02/03/received PY - 2005/3/2/pubmed PY - 2005/5/6/medline PY - 2005/3/2/entrez SP - 726 EP - 32 JF - Biochemical and biophysical research communications JO - Biochem. Biophys. Res. Commun. VL - 329 IS - 2 N2 - Peroxisome proliferator-activated receptor-gamma (PPARgamma) plays a critical role in peripheral glucose homeostasis and energy metabolism, and inhibits cardiac hypertrophy in non-diabetic animal models. The functional role of PPARgamma in the diabetic heart, however, is not fully understood. Therefore, we analyzed cardiac gene expression, metabolic control, and cardiac glucose uptake in male Zucker diabetic fatty rats (ZDF fa/fa) and lean ZDF rats (+/+) treated with the high affinity PPARgamma agonist pioglitazone or placebo from 12 to 24 weeks of age. Hyperglycemia, hyperinsulinemia, and hypertriglyceridemia as well as lower cardiac PPARgamma, glucose transporter-4 and alpha-myosin heavy chain expression levels were detected in diabetic ZDF rats compared to lean animals. Pioglitazone increased body weight and improved metabolic control, cardiac PPARgamma, glut-4, and alpha-MHC expression levels in diabetic ZDF rats. Cardiac [(18)F]fluorodeoxyglucose uptake was not detectable by micro-PET studies in untreated and pioglitazone treated ZDF fa/fa rats but was observed after administration of insulin to pioglitazone treated ZDF fa/fa rats. PPARgamma agonists favorably affect cardiac gene expression in type-2 diabetic rats via activation and up-regulation of cardiac PPARgamma expression whereas improvement of impaired cardiac glucose uptake in advanced type-2 diabetes requires co-administration of insulin. SN - 0006-291X UR - https://www.unboundmedicine.com/medline/citation/15737646/Pioglitazone_reverses_down_regulation_of_cardiac_PPARgamma_expression_in_Zucker_diabetic_fatty_rats_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0006-291X(05)00282-2 DB - PRIME DP - Unbound Medicine ER -